BIO logo

BIO

Bio-Rad Laboratories Inc. Class A

$297.88
+$4.21(+1.43%)
65
Overall
60
Value
90
Tech
47
Quality
Market Cap
$8.03B
Volume
199.92K
52W Range
$211.43 - $387.99
Target Price
$325.80
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$2.0B$2.1B$2.2B$2.3B$2.3B$2.5B$2.9B$2.8B$2.7B$2.6B
Total Revenue
$2.0B$2.1B$2.2B$2.3B$2.3B$2.5B$2.9B$2.8B$2.7B$2.6B
COST OF GOODS SOLD
Cost of Revenue
$897.8M$930.1M$972.5M$1.1B$1.1B$1.1B$1.3B$1.2B$1.2B$1.2B
GROSS PROFIT
Gross Profit
$1.1B$1.1B$-972.5M$-1.1B$-1.1B$1.4B$1.6B$1.6B$1.4B$1.4B
OPERATING EXPENSES
Operating Expenses
$955.0M$1.0B$1.1B$1.0B$1.0B$1.0B$1.1B$1.1B$1.1B$1.1B
Research & Development
$193.0M$205.9M$250.2M$199.2M$202.7M$226.6M$260.6M$256.9M$247.4M$295.9M
Research Expense
$193.0M$205.9M$250.2M$199.2M$202.7M$226.6M$260.6M$256.9M$247.4M$295.9M
Selling, General & Administrative
$762.0M$816.7M$806.8M$834.8M$824.6M$800.3M$877.1M$827.8M$841.7M$814.0M
Selling & Marketing Expenses
$762.0M$816.7M$806.8M$834.8M$824.6M$800.3M--------
General & Administrative Expenses
$-45.0M$-44.4M$-43.6M$-47.4M----$877.1M$827.8M$841.7M$814.0M
Salaries & Wages
$-17.0M$-19.7M$-23.4M$-27.8M$-35.6M$-41.6M$-7.4M$-8.8M----
Depreciation & Amortization
$-131.8M$-142.9M$-148.7M$-138.1M$-40.3M$-37.1M$137.6M$137.3M$145.9M$151.6M
Depreciation & Amortization
$-131.8M$-142.9M$-148.7M$-138.1M$-40.3M$-37.1M$137.6M$137.3M----
Amortization
$-36.5M$-33.5M$-29.4M$-27.0M$-24.1M$-28.8M$345.5M$406.9M$414.0M$411.1M
Other Operating Expenses
$-1.5M$-3.4M$-34.8M$-4.6M$-51.4M$-45.4M$-18.1M$-9.8M----
OPERATING INCOME
Operating income
$166.7M$115.5M$-2.0B$-2.1B$-2.1B$-2.1B$500.3M$482.6M$337.8M$269.0M
EBITDA
$167.5M$63.5M$120.8M$536.6M$2.2B$5.1B$5.6B$-4.5B$-654.8M$-2.3B
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$21.7M$21.9M$23.0M$24.0M$23.4M$21.9M$1.6M$38.1M$49.4M$48.9M
Net Non-Operating Interest Income/Expense
$-21.7M$-21.9M$-23.0M$-24.0M$-23.4M$-21.9M$-1.6M$-19.9M$-49.4M$-48.9M
Gain on Sale of Securities
$1.6M$800.0K$7.0M$606.2M$2.0B$4.5B$8.0M$2.3M----
Other Income/Expense
$-11.1M$-14.8M$-2.2B$-2.9B$-4.4B$-7.1B$-5.0B$-5.2B$1.1B$2.6B
Other Special Charges
$11.1M$14.8M$2.2B$2.3B$2.3B$2.6B$26.8M$44.6M$106.5M$90.3M
SPECIAL ITEMS
Restructring And Mn A Income
--$-12.5M--------$-11.2M$4.2M----
Special Income Charges
--$-62.3M$-11.5M$-292.5M--$35.3M$11.2M$-4.2M$-27.9M--
Impairment of Capital Assets
--$62.3M$11.5M$292.5M------------
PRE-TAX INCOME
EBIT
$167.5M$63.5M$120.8M$536.6M$2.3B$4.9B$5.5B$-4.7B$-800.7M$-2.3B
Pre-Tax Income
$145.8M$41.6M$97.8M$512.7M$2.3B$4.9B$5.4B$-4.7B$-850.1M$-2.3B
INCOME TAX
Tax Provision
$32.8M$15.6M$-24.4M$147.0M$502.4M$1.1B$1.2B$-1.1B$-212.8M$-498.3M
NET INCOME
Net Income
$113.1M$26.0M$122.2M$365.6M$1.8B$3.8B$4.3B$-3.6B$-637.3M$-1.8B
Net Income (Continuing Operations)
$113.1M$26.0M$122.2M$365.6M$1.8B$3.8B$4.3B$-3.6B$-637.3M$-1.8B
Net Income (Discontinued Operations)
$113.1M$26.0M$122.2M$365.6M$1.8B$3.8B$4.3B$-3.6B$-637.3M$-1.8B
Net Income (Common Stockholders)
$113.1M$26.0M$122.2M$365.6M$1.8B$3.8B$4.3B$-3.6B$-637.3M$-1.8B
TOTALS
Total Expenses
$1.9B$2.0B$2.0B$2.1B$2.1B$2.1B$2.4B$2.3B$2.3B$2.3B
SHARE & EPS DATA
Average Shares Outstanding
$29.2M$29.4M$29.7M$29.8M$29.8M$29.8M$29.8M$29.8M$29.2M$28.2M
Average Shares Outstanding (Diluted)
$29.4M$29.6M$30.0M$30.2M$30.2M$30.2M$30.2M$29.8M$29.2M$28.2M
Shares Outstanding
$29.4M$29.6M$29.8M$29.8M$29.9M$29.8M$29.9M$29.6M$28.5M$28.0M
Basic EPS
$3.87$0.88$4.12$12.25$58.93$127.86$142.33$-121.79$-21.82$-65.36
Basic EPS (Continuing Operations)
------------$142.33$-121.79$-21.82$-65.36
Diluted EPS
$3.85$0.88$4.07$12.1$58.27$126.2$140.56$-121.79$-21.82$-65.36
Diluted EPS (Continuing Operations)
------------$140.56$-121.79$-21.82--
OTHER METRICS
Gain On Sale Of Business
--$-400.0K$-1.2M--$-900.0K$1.3M--$-1.4M----
Gain On Sale Of P P E
$-300.0K$-600.0K$-8.1M$5.1M--$11.7M--$1.4M----
Non Recurring Operation Expense
--$-141.6K$-141.6K$-141.6K--$-35.3M--------
Other Gand A
$-45.0M$-44.4M$-43.6M$-47.4M----$877.1M$827.8M$841.7M$814.0M
Other Impairment Of Capital Assets
--$-46.4M$-7.0M$-800.0K$-5.8M$-4.6M$800.0K$11.9M----
Other Write Off
--------$-6.6M$-1.6M$-1.4M$-1.7M----
Rent And Landing Fees
$-45.0M$-44.4M$-43.6M$-47.4M------------
Selling Expense
$762.0M$816.7M$806.8M$834.8M$824.6M$800.3M--------
Write Down
------$-1.4M------------
Restruct
--$-12.5M--------$-11.2M$4.2M----

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2BIO$297.88+1.4%199.92K
3
4
5
6

Get Bio-Rad Laboratories Inc. Class A Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.